Chandra Bhagat Pharma Limited
Chandra Bhagat Pharma Limited, often referred to as CB Pharma, is a prominent player in the pharmaceutical industry, headquartered in India. Established in 1984, the company has made significant strides in the development and manufacturing of a diverse range of pharmaceutical products, including formulations, active pharmaceutical ingredients (APIs), and nutraceuticals. With a strong operational presence across various regions in India, CB Pharma is recognised for its commitment to quality and innovation. The company’s core offerings are distinguished by their adherence to stringent regulatory standards and a focus on research and development, ensuring that they meet the evolving needs of healthcare professionals and patients alike. Chandra Bhagat Pharma Limited has earned a reputable market position, marked by notable achievements in product development and a robust distribution network, solidifying its status as a trusted name in the pharmaceutical sector.
DitchCarbon Score
How does Chandra Bhagat Pharma Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Chandra Bhagat Pharma Limited's score of 14 is lower than 92% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Chandra Bhagat Pharma Limited's reported carbon emissions
Chandra Bhagat Pharma Limited, headquartered in India, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Chandra Bhagat Pharma may not have established formal climate commitments or initiatives aimed at reducing its carbon footprint. As the pharmaceutical industry increasingly focuses on sustainability, it is essential for companies like Chandra Bhagat Pharma to consider implementing measurable climate strategies to align with global efforts in combating climate change.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Chandra Bhagat Pharma Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
